Analytical Services CDMOs

Innovassynth Technologies (I) Ltd.

India

Innovassynth Technologies is a specialty chemicals and pharmaceutical intermediates manufacturer based in Khopoli, India. The company is a pioneer in offering commercial-scale nucleosides from India, and provides custom research, development, and contract manufacturing services across pharma intermediates, nucleosides, phosphoramidites, ADC linkers, organometallics, and specialty chemicals.

International Drug Development Institute(IDDI)

Belgium

IDDI (International Drug Development Institute) is a clinical data science CRO specializing in biostatistics, clinical data management, strategic consulting, and eClinical technologies. Founded in 1991, the company has completed over 1,500 clinical trials for 350+ clients, with 80% repeat business. IDDI's therapeutic focus is oncology and ophthalmology, representing 75% of their work.

JEWIM Pharmaceutical (Shandong) Co., Ltd. is a Chinese pharmaceutical company in transformation, focusing on innovative drugs and complex drug delivery systems including inhalation products, nasal sprays, and long-acting injectable microspheres. The company is an established CDMO/CMO partner for multinational pharma companies including Johnson & Johnson (Xian Janssen), Kenvue, and Bayer, with quality systems certified by US FDA and Australian TGA. Products are exported to over 80 countries.

Jubilant HollisterStier CMO

Canada

Jubilant HollisterStier CMO (subsidiary of Jubilant Pharma) specializes in sterile fill-finish, lyophilization, injectables, ophthalmics, otics, topicals, and liquids for pharmaceutical and biopharmaceutical clients. End-to-end services from process development to inspection and packaging. Facilities in Spokane, WA and Montreal, QC. Won AWB Manufacturer of the Year 2024 and Manufacturing Excellence Award 2025. Largest manufacturer by employees in Spokane area. 92% repeat customer rate. FDA registered with 4 FEI numbers, 28 inspections (6 NAI, 18 VAI, 4 OAI -- elevated regulatory risk).

Kingchem Life Science LLC

China

Kingchem Life Science LLC is a global small molecule CDMO specializing in the end-to-end development and manufacturing of APIs, intermediates, RSMs (regulated starting materials), excipients, and specialty chemicals. Their vertically integrated model spans from R&D through commercial production with facilities in St. Francis, Wisconsin (FDA-registered cGMP) and Fuxin, Liaoning, China, plus R&D in Dalian, China. They handle complex chemistry challenges, and their FDA facility (FEI 2129414) has had 9 inspections (1 NAI, 8 VAI, 0 OAI).

KINSY, S.L.

Spain

KINSY, S.L. is an independent Spanish CDMO with over 30 years of experience, located in Alhama de Murcia, specializing in the development, scale-up, and commercial production of pharmaceutical APIs and key intermediates under cGMP. They operate from a single site offering end-to-end services from early clinical stages through commercial manufacturing. KINSY is FDA-registered (FEI 3013310589) and holds ISO certification. They serve the fine chemical and pharmaceutical industry, working in close collaboration with partners on custom API synthesis.

KLEVA PHARMA (M.J. Kleva SA)

Greece

KLEVA Pharmaceuticals S.A. is a Greek pharmaceutical company established in 1974, specializing in contract manufacturing and technology transfer services. They operate two manufacturing sites in Greece, including a sterile area with filling capability expanded in 2019. KLEVA holds ISO 9001:2015 and EU GMP certification. Their R&D department develops generic pharmaceutical dossiers in CTD format, from patent search and API sourcing through formulation development, pilot-scale batches, stability studies, and dossier compilation. They have 190 marketing authorizations across Europe, Asia, Oceania, and Africa, serving over 50 customers in 30+ countries since 2012.

Kolon Biotech

South Korea

Kolon Biotech Inc. is a South Korean cell and gene therapy CDMO, part of the Kolon Group. They operate 17,000 sqm of facilities designed for both development and GMP manufacturing of cell and gene therapy products. Their B1 plant supports multiple simultaneous products and development projects, while B2 is optimized for mass production targeting global markets with flexible customization. Kolon Biotech is FDA-registered (FEI 3019016602) for analysis, API manufacture, labeling, manufacturing, and packaging. They offer end-to-end CDMO services aimed at shortening time-to-market, including a 2D Automated Closed Platform for large-scale adherent cell manufacturing.

Kraeber & Co GmbH

Germany

Kraeber & Co GmbH is an independent family-owned German company based near Hamburg that sells Active Pharmaceutical Ingredients (APIs), synthetically derived products and biological substances of animal or plant origin. They also operate contract manufacturing with GMP-certified, ISO-compliant facilities including cleanrooms (Class A, B, C, D), sterile filling, autoclaves, and centrifuges. Their Bioscience Solutions division develops and produces substances for medical devices, diagnostics, and laboratory purposes. They specialize in niche products including animal blood fractionation with over 30 years of experience.

Labcorp (incl. Labcorp Drug Development/Covance)

United States

Labcorp (including Labcorp Drug Development, formerly Covance) is one of the world's largest contract research organizations (CROs). They provide comprehensive drug development services including nonclinical development (toxicology, pharmacology, metabolism), central laboratory services (bioanalytical, biomarkers, genomics, companion diagnostics), and commercialization services. Labcorp supported 76% of all FDA-approved drugs in 2024. They operate across 100+ countries with services spanning from drug discovery to post-approval. While they offer CMC consulting services, their core business is contract research, not contract drug manufacturing.

Laboratorios Basi – Indústria Farmacêutica

Portugal

Laboratorios Basi - Industria Farmaceutica S.A. is a Portuguese pharmaceutical company whose mission is to develop, manufacture, market, and globally distribute medicines and therapeutic solutions built on European quality excellence with innovative technologies. They have over 240 pharmaceutical products registered across 17 therapeutic areas and are present in more than 60 countries. They operate two industrial units and offer contract manufacturing services for injectable products (small and large volume), gels, creams, ointments, syrups, oral solutions and suspensions, cutaneous solutions, and enemas. They also offer licensing, quality control, and R&D services. Their innovation arm operates through Basinnov.

Latitude Pharmaceuticals Inc

United States

Latitude Pharmaceuticals Inc is a San Diego, CA-based CRO/CMO (CRDMO) providing innovative drug formulation development and GMP manufacturing services. Founded in 2003, the company has completed over 900 pharmaceutical formulation development projects for 250+ client companies. Specializes in solving complex drug formulation challenges, particularly for insoluble APIs using their proprietary CLEARSOL platform. Provides GLP- and GMP-compliant manufacturing and analytical testing services for IND-enabling studies and Phase 1-2 clinical trial materials, including sterile injectables, fill/finish, lyophilization, vials, pre-filled syringes, and IV bags.

Laurus Bio

India

Laurus Bio is a subsidiary of Laurus Labs, an integrated research-driven biomanufacturing organization based in Bengaluru, India, with deep expertise in precision fermentation and recombinant technology. They engineer microbes as cell-factories to manufacture animal-free recombinant proteins and growth factors for biopharma, food, health, nutrition, and personal care markets. Offers precision fermentation CDMO and scale-up services, from clone development to large-scale manufacturing. Acquired as Richcore Lifesciences in 2020 and rebranded as Laurus Bio.

Leanbio

Spain

Leanbio is a Spanish biopharmaceutical CDMO founded in 2014 by Dr. Andreu Soldevila and Albert Font, specializing in end-to-end development and manufacturing of biological products including recombinant proteins, antibodies, bioconjugates, and mRNA. Offers both microbial and mammalian production platforms. Acquired by Reig Jofre to strengthen their CDMO capabilities. Currently building a new GMP biologics facility in Sant Quirze del Valles, Barcelona, with an additional 20M EUR investment, featuring over 4,000 sqm and three manufacturing areas: one each for microbial, mammalian, and mRNA production.

Lee Pharma Limited

India

Lee Pharma Limited is an Indian pharmaceutical company established in 1997 in Hyderabad, focused on the development, synthesis, and commercialization of Active Pharmaceutical Ingredients (APIs), intermediates, semi-finished dosage forms (pellets and granules), and finished formulations. Manufacturing facilities are approved by USFDA, EUGMP, and WHO GMP. Listed on CPHI Online as a CMO/CDMO and manufacturer. Serves partners in 30+ countries with a focus on Europe and Asia. Also has a CDMO services page and offers contract manufacturing services.

LFB Biomanufacturing

France

LFB Biomanufacturing is a French CDMO specializing in end-to-end development and GMP manufacturing of therapeutic antibodies and recombinant proteins. Part of the LFB Group, the company provides services from cell line development through GMP drug substance manufacturing at its facility in Ales, France. The facility is FDA- and ANSM-inspected and approved.

Lupin Limited (Lupin Manufacturing Solutions)

Brazil

Lupin Manufacturing Solutions (LMS) is the CDMO arm of Lupin Limited, one of India's largest pharmaceutical companies. LMS offers integrated CDMO services spanning API manufacturing, formulation development, and finished dosage form production. They operate 16 FDA-registered facilities with 512 FDA-approved products. They have recently expanded into oncology with a dedicated block at Vizag, India, and formed a strategic alliance with PolyPeptide for peptide supply chain scaling. Their extensive regulatory track record includes FDA, WHO, and multiple international approvals.

Marifarm proizvodnja in storitve d.o.o.

Slovenia

Marifarm d.o.o. is a Slovenian pharmaceutical company providing contract manufacturing services including finished dosage form manufacturing, project management, analytical services, logistics (GDP certified), herbal extract production, serialization systems, and microbiological quality control. The company is listed in pharmaceutical CMO industry databases and serves as a contract manufacturing partner for finished pharmaceutical products.

MFC Co., Ltd.

South Korea

MFC Co., Ltd. is a South Korean company established in 2008 specializing in the manufacture of APIs and key pharmaceutical intermediates. The company is GMP certified by KMFDS (Korea Ministry of Food and Drug Safety). MFC focuses on both original and generic API development, from new drug candidate research to commercial-scale production. The company has also established an AI-based formulation research center and is involved in developing essential medicines including acetaminophen APIs.

Microsize, LLC

United States

Microsize LLC is a US-based pharmaceutical CDMO with over 30 years of specialized experience in micronization and particle size reduction, operating from three FDA-inspected facilities totaling over 100,000 square feet. The company helps drug developers improve dissolution and bioavailability for poorly soluble and highly potent APIs. Microsize has processed hundreds of APIs in thousands of production campaigns and recently signed an agreement to acquire Lonza's Micro-Macinazione assets. The company also licensed The Solubility Company's SPA platform for advanced particle engineering.

Mipharm S.p.A

Italy

Mipharm S.p.A. is a Milan-based pharmaceutical CDMO and one of the largest pharma CDMO sites in Italy. The company specializes in contract development and manufacturing of pharmaceutical products including production, packaging, R&D, and clinical trial logistics. 20% of staff is dedicated to quality. FDA-inspected (6 inspections, 1 NAI, 5 VAI).

MoNo chem-pharm Produkte GmbH

Austria

MoNo chem-pharm Produkte GmbH is an Austrian pharmaceutical contract manufacturer founded in 2000, affiliated with Sigmapharm Arzneimittel GmbH (70+ years in healthcare). The company specializes in the development and production of all types of pharmaceutical liquids — sterile and non-sterile, aqueous, oily, alcoholic, and viscous. State-of-the-art facilities for aseptic production of sterile liquids and filling into vials. Listed on CPHI for contract manufacturing, logistics/distribution, and regulatory services.

MUNIT SA

Italy

MUNIT SA is a specialized contract micronization and milling company with 60+ years of experience, serving as the integrated CDMO partner for API particle size engineering. MUNIT operates through its affiliates Jetpharma (Switzerland) and Microchem (Italy). Services include micronization (jet milling for enhanced bioavailability), milling (coarser particle size reduction), sieving, blending, de-lumping, conditioning post-micronization, analytical services, and advisory support. FDA-registered with 9 FEI numbers and 16 FDA inspections (8 NAI, 8 VAI). Listed on CPHI as CMO/CDMO. 150+ customers worldwide, 500+ successful pharma and food industry projects.

Murli Krishna Pharma Pvt Ltd

India

Duplicate entry for Murli Krishna Pharma Private Ltd. (mkppl.com) - same company, same website domain. Indian pharmaceutical CDMO specializing in PFI and FDF products with CRAMS services.

Neuland Laboratories Ltd.

India

Neuland Laboratories is a global pure-play API CDMO headquartered in Hyderabad, India, established in 1984. The company specializes in the development and manufacturing of complex small molecule APIs and peptides, serving over 500 customers in 80+ countries. Neuland provides end-to-end services from pre-IND through commercial manufacturing with multi-product facilities.

Nippon Fine Chemical Co., Ltd.

Japan

Nippon Fine Chemical Co., Ltd. is a Japanese company providing CDMO services for lipid nanoparticles (LNP) and liposomes, along with manufacturing high-purity phospholipids, cholesterol, and functional lipids. The company established a new Shonan Lab at the Shonan Health Innovation Park for open innovation in pharmaceuticals. Nippon Fine Chemical's GMP system complies with ICH guidelines and has been inspected by US FDA and European EMA.

Nitto Avecia (incl. Nitto Avecia Pharma Services)

United States

Nitto Avecia (part of Nitto Denko Corporation) is a US-based CDMO specializing in oligonucleotide drug substance manufacturing with over 25 years of experience. The company provides comprehensive services from preclinical manufacturing (OliGrow service) through commercial scale, including analytical development, process development, drug substance manufacturing, process performance qualification (PPQ), quality control, and stability testing. It achieved ANVISA GMP certification in 2025.

NORCHIM (Norchim SAS)

France

Norchim SAS is a French fine chemical and API manufacturer, part of the Moehs Group. The company specializes in custom synthesis of pharmaceutical intermediates and active ingredients under GMP conditions, focusing on process R&D and pilot-scale production for clinical lots. Norchim has successfully passed FDA and French regulatory inspections and holds Japanese export accreditation.

Northeast Pharmaceutical Group (NEPG) is a large-scale comprehensive pharmaceutical enterprise in Shenyang, China, under Fangda Group. The company operates three major business segments: chemical synthetic API and bio-fermentation API, western medicinal preparations and micro-ecological preparations, and medical business distribution. NEPG is China's first Vitamin C producer and the inventor of the two-step fermentation technology for VC production, with the world's largest Piracetam production capacity.

Norwich Pharmaceuticals (now Norwich Pharma Services, part of Alvogen) is a US-based contract development and manufacturing organization with over 130 years of pharmaceutical manufacturing history in Norwich, New York. The company manufactures generic medications including capsules, tablets, and extended-release tablets. Norwich is FDA-registered with operations including analysis, labeling, manufacturing, packing, relabeling, and repacking, and has 3 FDA-approved products with strong inspection history (6 NAI out of 7).

NOSCH LABS PVT LTD

India

Nosch Labs is an Indian pharmaceutical company headquartered in Hyderabad with 4 manufacturing units in Telangana. Two units are dedicated to API production and two to semi-finished formulations/pellets. The company has 21+ years of experience in the pharmaceutical value chain covering APIs and semi-finished formulations, with accreditations including EU GMP, Russian GMP, KFDA, COFEPRIS, and WHO GMP.

Novotech

Australia

Novotech is a global full-service clinical research organization (CRO) headquartered in Australia, specializing as a biotech partner across all clinical trial phases. The company operates extensively in Asia-Pacific and globally, providing clinical trial management, regulatory advisory, and scientific consulting services for biotech and small to mid-sized pharma companies.

Nuray Chemicals Pvt Ltd

India

Nuray Chemicals Pvt Ltd is an Indian API manufacturer established in 2012, operating a USFDA-approved manufacturing facility in Kakkalur, Tamil Nadu. The company specializes in developing and manufacturing active pharmaceutical ingredients including Atropine Sulfate, Dapsone, Chlorzoxazone, L-Methyl folate, Piribedil, and Trientine Hydrochloride, with a focus on NCE chemistry requirements and contract manufacturing.

Oakwood Laboratories LLC is a US-based specialty pharmaceutical company and CDMO focused on advanced injectable drug delivery systems, particularly sustained-release and microsphere formulations. The company operates a GMP aseptic manufacturing facility in Solon, Ohio, providing contract development and manufacturing for long-acting injectable products.

Oligo Factory

United States

Oligo Factory is a Massachusetts-based custom DNA and RNA oligonucleotide CDMO providing GMP and RUO custom oligo solutions for therapeutics, diagnostics, and life sciences. The company has increased its synthesis capability 12-fold through a new 13,000 sq ft facility in Holliston, MA, producing from micrograms to hundreds of grams. Oligo Factory supports applications including ASOs, siRNA, CRISPR guide RNA, aptamers, and PCR/NGS diagnostics.

OmniParticles

United States

OmniParticles is a specialized nanomedicine CDMO providing end-to-end custom nanoparticle formulation and manufacturing services for early-stage drug development. The company leverages its proprietary INNOSURFACE platform technology for structural integration of diverse therapeutic agents with biocompatible delivery systems, and operates GMP-compliant facilities supporting drug substance manufacturing.

Oncotec Pharma Produktion GmbH is a German CDMO specializing in the development and aseptic manufacturing of cytostatic (anticancer) drugs. Founded in 1997, the company provides full-service contract manufacturing from lab-scale development through commercial production, with approximately 2,300 m2 of cleanroom space and isolator-protected production lines at its Dessau-Rosslau facility.

Onyx Scientific

United Kingdom

Onyx Scientific (now Onyx Atomica) is a small molecule CDMO specializing in process chemistry, solid state chemistry, and API manufacturing. The company provides integrated CMC services from process R&D and non-GMP scale-up through to GMP manufacture, operating from two facilities in Sunderland, UK with additional US presence.

Pace Life Sciences is a division of Pace Analytical Services LLC, operating as a full-service CDMO/CRO network across the United States. The company supports drug development across the entire lifecycle from preclinical research through commercialization, specializing in small molecules, biologics (proteins, peptides, monoclonal antibodies, ADCs), nucleic acids (oligonucleotides, mRNA, plasmid DNA), and gene therapies. Recognized by PharmaSource as a Top CDMO in the United States. Operates 9+ strategically located sites including a sterile fill-finish Center of Excellence in Salem, NH.

Panvo Organics Pvt Ltd

India

Panvo Organics Pvt Ltd is an Indian manufacturer of Active Pharmaceutical Ingredients (APIs), Nutraceutical Ingredients, novel formulations, and sustainable agriculture inputs. The company's manufacturing facility is US FDA inspected and WHO-GMP certified, spread over 100,000 sq ft in Gummidipoondi (near Chennai), Tamil Nadu. Products include pharmaceutical APIs, drug intermediates, and nutraceutical ingredients. The company holds a patent for novel Chitosan applications and has DSIR-recognized in-house R&D. Also listed as a top CMO for small molecule API manufacturing.

Paras Biopharmaceuticals Finland Oy

Finland

Paras Biopharmaceuticals Finland Oy is a Finnish biologics CDMO based in Oulu, Finland, specializing in contract development and microbial biologics manufacturing. The company has a fully owned 25,000 sq ft state-of-the-art biologics production plant. Major activities include Biologics CDMO services and biologics technology development, including the proprietary Diabrid Platform. Recognized as one of the fastest-growing companies in Nordic biotechnology. Currently investing in expansion of its Oulu production site.

Parexel International (MA) Corporation

Argentina

Parexel is a global contract research organization (CRO) providing clinical trial management, regulatory consulting, and biopharmaceutical development services. With over 24,000 professionals and 50+ clinical sites across five continents, the company offers Phase I-IV clinical trial services, CMC regulatory strategy, and real-world evidence generation. Parexel is primarily a CRO, not a drug manufacturer.

Peptide Institute Inc.

Japan

Peptide Institute, Inc. has been contributing to the advancement of life sciences since 1977, serving over 10,000 scientists. The company provides both catalog peptide products for research and GMP peptide API manufacturing services from R&D through commercial scale. Peptide Institute offers custom peptide synthesis (including long peptides, modified peptides, cyclic peptides, glycopeptides), carbohydrate synthesis, and peptide drug production under GMP conditions.

Peptide Synthetics Ltd

United Kingdom

Peptide Synthetics Ltd, the custom peptide synthesis service from Peptide Protein Research (PPR Ltd), is a UK-based company specializing in custom synthesis of synthetic peptides and peptide-based molecules. The company provides peptides from milligram to gram quantities at purities from crude to >98%, with sequences from 2 to 60+ amino acids. Services include biotin labeling, fluorescent labeling, phosphopeptides, stable isotopes, and antibody production peptides. Listed in peptide CDMO market reports.

Pharmaffiliates Private Limited

India

Pharmaffiliates Private Limited is an India-based CRDMO and impurity standard manufacturer that has been USFDA-inspected. The company provides pharmaceutical reference standards, impurities, metabolites, stable isotopes, API synthesis, analytical services, regulatory support (DMF/ANDA submissions), and GMP/GLP training. It serves pharmaceutical, biotech, API manufacturers, and CRO clients globally.

PharmaResources (Kaiyuan) Co., Ltd.

China

PharmaResources (Kaiyuan) Co., Ltd. is a CRO/CDMO subsidiary of PharmaResources (Shanghai) Co., Ltd., based in Kaiyuan City, Liaoning Province, China. The Kaiyuan facility is a GMP-certified manufacturer specializing in medicinal chemistry and DMPK services. The company offers CDMO services including API manufacturing, with specific products listed on CPHI Online including Ticagrelor, Huperzine-A intermediates, and Peramivir trihydrate. Note: the pharmaresources.com domain now redirects to a weight loss supplement website unrelated to this company; the actual company operates via PharmaResources Shanghai's website.

Pharmatory Ltd

Finland

Pharmatory Ltd is a private Finnish CDMO specializing in small molecule synthesis, API process R&D, and cGMP contract manufacturing of active pharmaceutical ingredients. Founded in 2001 in Oulu, Finland, the company serves both NCE development projects and commercial products. Pharmatory has a worldwide customer base of pharma companies in both human and veterinary health. The company recently received investment from MB Funds to support growth. With 11-50 employees, Pharmatory is a compact, customer-oriented API specialist known for high dedication to customer success and quality. Recently celebrated its 25th anniversary.

PharmIdea is a Latvian CDMO located in Olaine, Latvia, specializing in sterile drug development, commercial production, and worldwide supply of pharmaceutical products. The company focuses on sterile drugs in vials, offering contract manufacturing services including product development. PharmIdea has completed CTDs for out-licensing and provides contract manufacturing of sterile injectables such as Levosimendan concentrate for solution for infusion (small batch), Caspofungin, and Carbetocin. The company has partnered with Lidds for manufacturing NZ-TLR9 formulation against solid tumors.